Roche Diagnostics, the world’s largest biotechnology company, has launched its new diagnostics legal entity in Nigeria in a key move to boost access to healthcare in the country.
With this opening, Nigeria joins five other networks across Africa, including South Africa, Egypt, Morocco, Kenya and Côte d’Ivoire, making diagnostics accessible at the point of need in a continent that houses more than 1.5 million people.
This expansion aligns with Roche’s 10-Year Diagnostics Strategy for Africa, which aims to increase access to in-vitro diagnostics (IVD) tenfold. As one of Africa’s largest economies and most populous nations, Nigeria presents significant opportunities for healthcare investment and innovation.